Figure 1.
Clinical effectiveness studies of vedolizumab in ulcerative colitis.
Notes: *At week 14, **data not available for steroid-free remission.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.